O929 Sustained levels of total and neutralising antibodies and favourable long term safety with the HPV-16/18 AS04-adjuvanted vaccine (Cervarix®): Follow-up to 7.3 years

✍ Scribed by De Carvalho, N.; Roteli-Martins, C.; Teixeira, J.; Naud, P.; De Borba, P.; Zahaf, T.; Sanchez, N.; Schuind, A.

• Book ID: 122306470
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 70 KB
• Volume: 107
• Category: Article
• ISSN: 0020-7292
• DOI: 10.1016/S0020-7292(09)61302-3